{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:50:12Z","timestamp":1788839412138,"version":"build-2803163510"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key Plan for Scientific Research and Development of China","award":["2021YFC0864500, 2022YFF1203100"],"award-info":[{"award-number":["2021YFC0864500, 2022YFF1203100"]}]},{"name":"National Key Plan for Scientific Research and Development of China","award":["2022YFC2604100"],"award-info":[{"award-number":["2022YFC2604100"]}]},{"name":"National Key Plan for Scientific Research and Development of China","award":["2022YFC2303400, 2023YFC3043300"],"award-info":[{"award-number":["2022YFC2303400, 2023YFC3043300"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["92169205"],"award-info":[{"award-number":["92169205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82241072"],"award-info":[{"award-number":["82241072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82150205, 32270983"],"award-info":[{"award-number":["82150205, 32270983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wanke Scientific Research Program","award":["20221080056"],"award-info":[{"award-number":["20221080056"]}]},{"name":"Hong Kong Research Grants Council Collaborative Research Fund","award":["C7156-20G"],"award-info":[{"award-number":["C7156-20G"]}]},{"name":"The Health@InnoHK, Innovation and Technology Commission of Hong Kong"},{"name":"The Emergency Key Program of Guangzhou Laboratory","award":["EKPG22-01"],"award-info":[{"award-number":["EKPG22-01"]}]},{"name":"The Hong Kong Research Grants Council Theme-Based Research Scheme","award":["T11-709\/21-N"],"award-info":[{"award-number":["T11-709\/21-N"]}]},{"name":"The Hong Kong Health and Medical Research Fund","award":["COVID1903010 and COVID190123"],"award-info":[{"award-number":["COVID1903010 and COVID190123"]}]},{"name":"National Key Plan for Scientific Research and Development of China","award":["2021YFC2300104 and 2022YFF1203103"],"award-info":[{"award-number":["2021YFC2300104 and 2022YFF1203103"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["32171202"],"award-info":[{"award-number":["32171202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The ongoing evolution and immune escape of SARS-CoV-2, alongside the potential threat of SARS-CoV-1 and other sarbecoviruses, underscore the urgent need for effective strategies against their infection and transmission. This study highlights the discovery of nanobodies from immunized alpacas, which demonstrate exceptionally broad and potent neutralizing capabilities against the recently emerged and more divergent SARS-CoV-2 Omicron subvariants including JD.1.1, JN.1, KP.3, KP.3.1.1, as well as SARS-CoV-1 and coronaviruses from bats and pangolins utilizing receptor ACE2. Among these, Tnb04-1 emerges as the most broad and potent, binding to a conserved hydrophobic pocket in the spike\u2019s receptor-binding domain, distinct from the ACE2 binding site. This interaction disrupts the formation of a proteinase K-resistant core, crucial for viral-cell fusion. Notably, intranasal administration of Tnb04-1 in Syrian hamsters effectively prevented respiratory infection and transmission of the authentic Omicron XBB.1.5 subvariant. Thus, Thb04-1 holds promise in combating respiratory acquisition and transmission of diverse sarbecoviruses.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012625","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T18:41:27Z","timestamp":1731350487000},"page":"e1012625","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1"],"prefix":"10.1371","volume":"20","author":[{"given":"Haodi","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qile","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Yunfei Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-509X","authenticated-orcid":true,"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"ppat.1012625.ref001","article-title":"WHO declares end to COVID-19\u2019s emergency phase","author":"M. Lenharo","year":"2023","journal-title":"Nature"},{"key":"ppat.1012625.ref002","article-title":"Daily briefing: COVID-19 is no longer an international health emergency","author":"F. Graham","year":"2023","journal-title":"Nature"},{"issue":"9","key":"ppat.1012625.ref003","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41591-023-02377-6","article-title":"Lessons from COVID-19 must be learned before the next outbreak","volume":"29","author":"I Hassan","year":"2023","journal-title":"Nature Medicine"},{"issue":"10","key":"ppat.1012625.ref004","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1016\/S1473-3099(23)00555-8","article-title":"Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6","volume":"23","author":"Q Wang","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ppat.1012625.ref005","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","article-title":"Virological characteristics of the SARS-CoV-2 JN.1 variant","volume":"24","author":"Y Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"ppat.1012625.ref006","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Y Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ppat.1012625.ref007","article-title":"Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant","author":"Y Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ppat.1012625.ref008","doi-asserted-by":"crossref","first-page":"2402880","DOI":"10.1080\/22221751.2024.2402880","article-title":"Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages","author":"Q Wang","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"ppat.1012625.ref009","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"M Cox","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"ppat.1012625.ref010","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-022-01248-5","article-title":"The humoral response and antibodies against SARS-CoV-2 infection","volume":"23","author":"H Qi","year":"2022","journal-title":"Nat Immunol"},{"issue":"6507","key":"ppat.1012625.ref011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1126\/science.abd2321","article-title":"Structural basis of a shared antibody response to SARS-CoV-2","volume":"369","author":"M Yuan","year":"2020","journal-title":"Science"},{"issue":"7821","key":"ppat.1012625.ref012","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"DF Robbiani","year":"2020","journal-title":"Nature"},{"issue":"7885","key":"ppat.1012625.ref013","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","article-title":"Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy","volume":"599","author":"R Yamin","year":"2021","journal-title":"Nature"},{"issue":"7839","key":"ppat.1012625.ref014","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strateg ies","volume":"588","author":"CO Barnes","journal-title":"Nature"},{"issue":"6566","key":"ppat.1012625.ref015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.abh2315","article-title":"Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study","volume":"374","author":"KM Hastie","year":"2021","journal-title":"Science"},{"issue":"4","key":"ppat.1012625.ref016","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41590-023-01449-6","article-title":"Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants","volume":"24","author":"B Ju","year":"2023","journal-title":"Nat Immunol"},{"issue":"1","key":"ppat.1012625.ref017","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41591-022-02092-8","article-title":"Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice","volume":"29","author":"SM Scheaffer","year":"2023","journal-title":"Nature Medicine"},{"issue":"16","key":"ppat.1012625.ref018","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"D Li","year":"2021","journal-title":"Cell"},{"issue":"15","key":"ppat.1012625.ref019","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJMoa2108453","article-title":"Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors","volume":"385","author":"CW Tan","year":"2021","journal-title":"N Engl J Med"},{"issue":"6523","key":"ppat.1012625.ref020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.abe4747","article-title":"Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2","volume":"370","author":"Y Xiang","year":"2020","journal-title":"Science"},{"issue":"6530","key":"ppat.1012625.ref021","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6230","article-title":"Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape","volume":"371","author":"PA Koenig","year":"2021","journal-title":"Science"},{"issue":"8","key":"ppat.1012625.ref022","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","volume":"184","author":"W Dejnirattisai","year":"2021","journal-title":"Cell"},{"issue":"6549","key":"ppat.1012625.ref023","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"L Stamatatos","year":"2021","journal-title":"Science"},{"issue":"6529","key":"ppat.1012625.ref024","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"JM Dan","year":"2021","journal-title":"Science"},{"issue":"7","key":"ppat.1012625.ref025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"DS Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"7867","key":"ppat.1012625.ref026","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","volume":"595","author":"JS Turner","year":"2021","journal-title":"Nature"},{"issue":"7821","key":"ppat.1012625.ref027","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"L Liu","year":"2020","journal-title":"Nature"},{"issue":"1","key":"ppat.1012625.ref028","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1038\/s41467-022-35642-2","article-title":"Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4\/5 and diverse sarbecoviruses.","volume":"13","author":"M Li","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"ppat.1012625.ref029","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"D Wrapp","year":"2020","journal-title":"Cell"},{"key":"ppat.1012625.ref030","doi-asserted-by":"crossref","first-page":"766821","DOI":"10.3389\/fimmu.2021.766821","article-title":"A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.","volume":"12","author":"S Shan","journal-title":"Frontiers in immunology"},{"issue":"637","key":"ppat.1012625.ref031","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi9215","article-title":"A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.","volume":"14","author":"P Zhou","year":"2022","journal-title":"Sci Transl Med."},{"issue":"7898","key":"ppat.1012625.ref032","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Y Cao","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"ppat.1012625.ref033","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-Co V-2","volume":"602","author":"L Liu","journal-title":"Nature"},{"issue":"7898","key":"ppat.1012625.ref034","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"E Cameroni","year":"2022","journal-title":"Nature"},{"key":"ppat.1012625.ref035","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn8897","article-title":"Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529","volume":"376","author":"T Zhou","year":"2022","journal-title":"Science"},{"key":"ppat.1012625.ref036","article-title":"Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 an d FLip variants","author":"P Qu","journal-title":"Cell."},{"key":"ppat.1012625.ref037","article-title":"XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1.","author":"Q Wang","year":"2024","journal-title":"Cell Host Microbe."},{"issue":"12","key":"ppat.1012625.ref038","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/S1473-3099(23)00682-5","article-title":"Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1","volume":"23","author":"R Lassauniere","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ppat.1012625.ref039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1473-3099(23)00070-1","article-title":"Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 iso late","volume":"23","author":"R Uraki","journal-title":"The Lancet Infectious diseases"},{"issue":"6","key":"ppat.1012625.ref040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1473-3099(23)00278-5","article-title":"Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant","volume":"23","author":"D Yamasoba","journal-title":"The Lancet Infectious diseases"},{"issue":"3","key":"ppat.1012625.ref041","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","article-title":"SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency","volume":"187","author":"L Zhang","year":"2024","journal-title":"Cell"},{"issue":"7","key":"ppat.1012625.ref042","doi-asserted-by":"crossref","first-page":"110812","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"K Westendorf","journal-title":"Cell reports"},{"issue":"7815","key":"ppat.1012625.ref043","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV anti body","volume":"583","author":"D Pinto","journal-title":"Nature"},{"issue":"6491","key":"ppat.1012625.ref044","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"M Yuan","journal-title":"Science"},{"issue":"12","key":"ppat.1012625.ref045","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/protein\/gzs051","article-title":"Generation of a dual-functional split-reporter protein for monitoring membrane fusion using self-associating split GFP","volume":"25","author":"H Ishikawa","year":"2012","journal-title":"Protein Eng Des Sel"},{"issue":"1","key":"ppat.1012625.ref046","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41467-020-20501-9","article-title":"Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry","volume":"12","author":"J Ge","year":"2021","journal-title":"Nat Commun"},{"issue":"13","key":"ppat.1012625.ref047","doi-asserted-by":"crossref","first-page":"111004","DOI":"10.1016\/j.celrep.2022.111004","article-title":"Superimmunity by pan-sarbecovirus nanobodies","volume":"39","author":"Y Xiang","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"ppat.1012625.ref048","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41467-022-31259-7","article-title":"A broadly neutralizing antibody protects Syrian hamsters against SARS- CoV-2","volume":"13","author":"B Zhou","journal-title":"Omicron challenge. Nature communications"},{"issue":"6604","key":"ppat.1012625.ref049","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.abn8939","article-title":"Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters","volume":"377","author":"S Yuan","year":"2022","journal-title":"Science"},{"issue":"7902","key":"ppat.1012625.ref050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"KPY Hui","year":"2022","journal-title":"Nature"},{"issue":"2","key":"ppat.1012625.ref051","doi-asserted-by":"crossref","first-page":"2245921","DOI":"10.1080\/22221751.2023.2245921","article-title":"SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and in jury in Syrian hamsters1.","volume":"12","author":"B Zhou","journal-title":"Emerging microbes & infections."},{"issue":"23","key":"ppat.1012625.ref052","article-title":"Structural insights into the cross-neutralization of SARS-CoV and SARS -CoV-2 by the human monoclonal antibody 47D11.","volume":"7","author":"J Fedry","journal-title":"Sci Adv.PubMed Central PMCID"},{"issue":"1","key":"ppat.1012625.ref053","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.chom.2021.11.013","article-title":"The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants","volume":"30","author":"C Liu","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ppat.1012625.ref054","doi-asserted-by":"crossref","first-page":"697074","DOI":"10.3389\/fimmu.2021.697074","article-title":"Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.","volume":"12","author":"M Li","year":"2021","journal-title":"Front Immunol."}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T18:42:01Z","timestamp":1731350521000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012625"}},"subtitle":[],"editor":[{"given":"F\u00e9lix A.","family":"Rey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012625","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]}}}